Early reports of monoallelic loss of the beclin 1 (BECN1) encoding gene in 40 to 75% of breast, prostate, and ovarian cancers led to describing autophagy as a tumor suppressor [31]. This evidence concerns the gene BECN1 and ovarian carcinoma.